A Clinical Trial to Evaluate the Efficacy and Safety of HL301 Versus Placebo in Acute Bronchitis Patients
Status:
Completed
Trial end date:
2017-08-28
Target enrollment:
Participant gender:
Summary
A Multicenter, Randomized, Double-blinded, Placebo-controlled, Parallel, Phase II Clinical
Trial to Evaluate the Efficacy and Safety of HL301 versus Placebo in acute bronchitis
patients.
Endpoint: BSS, The improvement and improvement rate of the tester for the treatment response,
The satisfaction of the subject, Total usage of Acetaminophen